General Electric Co.

$10.71

+0.63 (+0.01%) Today
1 Day1D

5 Days5D

1 Month1M

6 Months6M

YTDYTD

1 Year1Y

2 Years2Y

5 Years5Y

MaxMax

About

General Electric Co. is a technology and financial services company. It operates through the following segments: Power, Renewable Energy, Aviation, Healthcare, and Capital. The Power segment offers technologies, solutions, and services related to energy production, which includes gas and steam turbines, generators, and power generation services. The Renewable Energy segment provides wind turbine platforms, hardware & software, offshore wind turbines, solutions, products & services to hydropower industry, blades for onshore & offshore wind turbines, and high voltage equipment. The Aviation segment provides jet engines & turboprops for commercial airframes, maintenance, component repair, and overhaul services, as well as replacement parts, additive machines & materials, and engineering services. The Healthcare segment provides healthcare technologies in medical imaging, digital solutions, patient monitoring, and diagnostics, drug discovery, biopharmaceutical manufacturing technologies and performance enhancement solutions. The Capital segment leases & finances aircraft, aircraft engines and helicopters, and also provides financial and underwriting solutions. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Boston, MA.

CEO

H. Lawrence Culp

Employees

205000

Headquarters

5 Necco Street Boston, MA, 02210

Founded

1892

Market Cap

General Electric Co. News

John Grisham book turns spotlight on futuristic cancer treatment Mar 14, 2016

(Reuters) – A new book by bestselling author John Grisham is giving new impetus to a handful of companies striving to develop what they say could be a trailblazing treatment for cancer and Alzheimer’s disease. “The Tumor” is a fictional account of a 35-year-old man with brain cancer who, a decade into the future, is […]

FDA Approves GE Brain Imaging Tool for Alzheimer’s Oct 25, 2013

The U.S. Food and Drug Administration on Friday approved a radioactive imaging chemical from General Electric to help screen patients for Alzheimer’s disease and dementia. The drug, Vizamyl, is an injection of radioactive material designed to highlight abnormal brain plaque in medical imaging scans. Dementia caused by Alzheimer’s is associated with buildup of the plaque,…

GE, University of Washington to Develop ‘Diagnostics-on-Demand’ Device Aug 08, 2013

You’ve heard of on-demand TV, now imagine on-demand medical diagnosis – anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of…

GE Scientists in Technology “Relay Race” Against Cancer May 20, 2013

NISKAYUNA, N.Y.–(BUSINESS WIRE)–May 20, 2013–To commemorate National Cancer Research Month, a team of scientists from GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are joined together in a technology “relay race” against cancer. They collectively are driving technologies across the entire continuum of cancer care with the end-goal of…

Med-tech lobbying spend keeps growing in Q3 Dec 19, 2011

Lobbying

Medical device industry lobbyists ramped up their spending during the 3rd quarter, dropping nearly $32 million on Washington in the 3 months ended Sept. 30.

The reports mark a continued incline for the industry’s spending on Capitol Hill, which hit nearly $28 million last quarter and $20 million in Q1.

The American Medical Assn. led the charge in Q3, doling out more than $7 million, up from last quarter’s $4.3 million.